This recruiter is online.

This is your chance to shine!

Apply Now

Postdoctoral Researcher - Pancreatic Cancer

Toronto, ON
  • Number of positions available : 1

  • To be discussed
  • Full time
  • Starting date : 1 position to fill as soon as possible

The University Health Network, where “above all else the needs of patients come first”, encompasses Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute and the Michener Institute of Education. The breadth of research, the complexity of the cases treated, and the magnitude of its educational enterprise has made UHN a national and international resource for patient care, research and education. With a long tradition of ground-breaking firsts and a purpose of “Transforming lives and communities through excellence in care, discovery and learning”, the University Health Network (UHN), Canada’s largest research teaching hospital, brings together over 16,000 employees, more than 1,200 physicians, 8,000+ students, and many volunteers. UHN is a caring, creative place where amazing people are amazing the world.

Position Summary
The DaCosta Research Lab at the Princess Margaret Cancer Centre (PMCC) (http://dacostalab.ca) is currently seeking a Postdoctoral Fellow to join our preclinical pancreatic cancer research team.

The successful applicant will be part of a research group that uses intravital fluorescence microscopy imaging in live animals to study pancreatic cancer initiation, biology, progression, and response to novel radiotherapeutic treatment strategies using advanced animal models of cancer, within the mouse pancreas. The successful applicant will help to study the pancreatic tumor microenvironment in an orthotopic setting, with a focus on tumor vasculature, hypoxia, immune cells, stroma, and other key aspects in vivo. An important area to investigate when in this role will include the study of novel radio-sensitizers and their role in pancreatic treatment response. A key additional focus area will be on the use of immune- and cell therapies for treatment of pancreatic cancer.

The successful applicant will also collaborate extensively with other labs across UHN, as well as external collaborators. The position status is temporary full-time (1 year) with the potential to extend to permanent full-time based on the candidate’s performance and compatibility with the research team and lab objectives. The ideal candidate will have a clear career plan to become a principal investigator or independent scientist seeking an academic faculty position.

Duties

UHN uses email to communicate with selected candidates. Please ensure you check your email regularly.

Please be advised that a Criminal Record Check may be required of the successful candidate. Should it be determined that any information provided by a candidate be misleading, inaccurate or incorrect, UHN reserves the right to discontinue with the consideration of their application.

All UHN Employees are required to be fully vaccinated with a COVID-19 vaccine series, approved by Health Canada or the World Health Organization, as a condition of hire. Proof of COVID-19 vaccination will be required. Should you be the successful candidate, you will be required to comply with UHN’s mandatory Vaccination Policy that is in effect.

UHN is an equal opportunity employer committed to an inclusive recruitment process and workplace. Requests for accommodation can be made at any stage of the recruitment process. Applicants need to make their requirements known.

We thank all applicants for their interest, however, only those selected for further consideration will be contacted.


Requirements

Level of education

undetermined

Work experience (years)

undetermined

Written languages

undetermined

Spoken languages

undetermined